These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2261014)

  • 41. Cardiac electrophysiological effects of falipamil in the conscious dog: comparison with alinidine.
    Boucher M; Chassaing C; Chapuy E
    Eur J Pharmacol; 1996 Jun; 306(1-3):93-8. PubMed ID: 8813620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
    Rampa A; Chiarini A; Bisi A; Budriesi R; Valenti P
    Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrophysiologic properties of falipamil (AQA-39)--a new bradycardiac agent.
    Lévy S; Mètge M; Hilaire J; Cointe R; Bru P; Eychenne JL; Gérard R
    Eur Heart J; 1987 Nov; 8(11):1236-40. PubMed ID: 3691560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of zatebradine, a specific bradycardic agent, on ischemia-induced arrhythmias in anesthetized rabbits.
    Bril A; Forest MC; Cheval B; Landais L; Gout B
    Pharmacology; 1994 May; 48(5):308-19. PubMed ID: 8016191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation.
    Tasso B; Budriesi R; Vazzana I; Ioan P; Micucci M; Novelli F; Tonelli M; Sparatore A; Chiarini A; Sparatore F
    J Med Chem; 2010 Jun; 53(12):4668-77. PubMed ID: 20509610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical pharmacology of two specific bradycardiac agents.
    Franke H; Su CA; Schumacher K; Seiberling M
    Eur Heart J; 1987 Dec; 8 Suppl L():91-8. PubMed ID: 3451888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.
    Amini M; Golabchifar AA; Dehpour AR; Pirali HM; Shafiee A
    Arzneimittelforschung; 2002; 52(1):21-6. PubMed ID: 11838270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine.
    Wynn H; Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
    Drug Des Deliv; 1988 Nov; 3(3):245-56. PubMed ID: 2855579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformationally constrained calcium channel blockers: novel mimics of 1-benzazepin-2-ones.
    Barrish JC; Spergel SH; Moreland S; Grover G; Hedberg SA; Pudzianowski AT; Gougoutas JZ; Malley MF
    Bioorg Med Chem; 1993 Oct; 1(4):309-25. PubMed ID: 8081861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AQA 39*, a new bradycardic agent which blocks myocardial calcium (Ca) channels in a frequency- and voltage-dependent manner.
    Trautwein W; Pelzer D; McDonald TF; Osterrieder W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):228-32. PubMed ID: 6275277
    [No Abstract]   [Full Text] [Related]  

  • 51. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects on atrio-ventricular conduction of alinidine and falipamil injected into the AV node artery of the anesthetized dog.
    Takeda M; Furukawa Y; Ogiwara Y; Saegusa K; Haniuda M; Akahane K; Chiba S
    Arch Int Pharmacodyn Ther; 1989; 297():39-48. PubMed ID: 2730241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.
    Dong H; Sheng JZ; Lee CM; Wong TM
    Br J Pharmacol; 1993 May; 109(1):113-9. PubMed ID: 8495235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. (+/-)-2-(3-Piperidyl)-1,2,3,4-tetrahydroisoquinolines as a new class of specific bradycardic agents.
    Kubota H; Kakefuda A; Watanabe T; Taguchi Y; Ishii N; Masuda N; Sakamoto S; Tsukamoto Si
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2155-8. PubMed ID: 12798325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives.
    Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
    J Med Chem; 1989 Oct; 32(10):2381-8. PubMed ID: 2795609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
    Atwal KS; Rovnyak GC; Schwartz J; Moreland S; Hedberg A; Gougoutas JZ; Malley MF; Floyd DM
    J Med Chem; 1990 May; 33(5):1510-5. PubMed ID: 2329573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
    Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
    J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent.
    O'Brien P; Drage D; Saeian K; Brooks HL; Warltier DC
    Am Heart J; 1992 Mar; 123(3):566-74. PubMed ID: 1539507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Selective I(f) channel inhibition: an alternative for treating coronary artery disease?].
    Schipke JD; Büter I; Hohlfeld T; Schmitz-Spanke S; Gams E
    Herz; 2006 Feb; 31(1):55-74. PubMed ID: 16502273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs.
    Gross GJ; Daemmgen JW
    J Pharmacol Exp Ther; 1986 Aug; 238(2):422-8. PubMed ID: 3735124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.